These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis. Shin I, Park YW, Sim Y, Choi SH, Ahn SS, Chang JH, Kim SH, Lee SK, Jain R. Acta Neuropathol Commun; 2024 Aug 10; 12(1):128. PubMed ID: 39127694 [Abstract] [Full Text] [Related]
4. Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas. Broniscer A, Chamdine O, Hwang S, Lin T, Pounds S, Onar-Thomas A, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA. Acta Neuropathol; 2016 Feb 10; 131(2):299-307. PubMed ID: 26744350 [Abstract] [Full Text] [Related]
5. Gliomatosis cerebri: no evidence for a separate brain tumor entity. Herrlinger U, Jones DTW, Glas M, Hattingen E, Gramatzki D, Stuplich M, Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet M, Hovestadt V, Capper D, Steinbach JP, von Deimling A, Lichter P, Pfister SM, Weller M, Reifenberger G. Acta Neuropathol; 2016 Feb 10; 131(2):309-319. PubMed ID: 26493382 [Abstract] [Full Text] [Related]
8. Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients. Georgakis MK, Tsivgoulis G, Pourtsidis A, Petridou ET. J Child Neurol; 2019 Jun 10; 34(7):394-401. PubMed ID: 30887873 [Abstract] [Full Text] [Related]
10. Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series. Anghileri E, Schettino C, Pollo B, Farinotti M, Silvani A, Paterra R, Patanè M, DiMeco F, Bruzzone MG, Eoli M, Cuccarini V. Neurol Sci; 2020 Aug 10; 41(8):2111-2120. PubMed ID: 32114667 [Abstract] [Full Text] [Related]
11. Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis. Georgakis MK, Tsivgoulis G, Spinos D, Liaskas A, Herrlinger U, Petridou ET. World Neurosurg; 2018 Dec 10; 120():e818-e854. PubMed ID: 30172970 [Abstract] [Full Text] [Related]
12. Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data. Georgakis MK, Tsivgoulis G, Spinos D, Dimitriou NG, Kyritsis AP, Herrlinger U, Petridou ET. J Neurooncol; 2018 Nov 10; 140(2):467-475. PubMed ID: 30117023 [Abstract] [Full Text] [Related]
13. Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas. Divé I, Steidl E, Wagner M, Filipski K, Burger MC, Franz K, Harter PN, Bähr O, Fokas E, Herrlinger U, Steinbach JP. Oncology; 2021 Nov 10; 99(4):215-224. PubMed ID: 33472203 [Abstract] [Full Text] [Related]
14. Incidence and survival of gliomatosis cerebri: a population-based cancer registration study. Georgakis MK, Spinos D, Pourtsidis A, Psyrri A, Panourias IG, Sgouros S, Petridou ET. J Neurooncol; 2018 Jun 10; 138(2):341-349. PubMed ID: 29464663 [Abstract] [Full Text] [Related]
16. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. Seiz M, Tuettenberg J, Meyer J, Essig M, Schmieder K, Mawrin C, von Deimling A, Hartmann C. Acta Neuropathol; 2010 Aug 10; 120(2):261-7. PubMed ID: 20514489 [Abstract] [Full Text] [Related]
18. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy. Kandula S, Saindane AM, Prabhu RS, Hanasoge S, Patel KR, Shu HK, Curran WJ, Crocker IR. Cancer; 2014 Sep 01; 120(17):2713-20. PubMed ID: 24845411 [Abstract] [Full Text] [Related]
19. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience. Jung TY, Yoon MS, Kim YH, Jung S, Kim IY, Jang WY, Moon KS, Lee KH, Kim SK. Clin Neurol Neurosurg; 2015 Mar 01; 130():1-5. PubMed ID: 25569296 [Abstract] [Full Text] [Related]